Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Weitz-Schmidt

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Therapeutic Drug Monitoring|December 1, 2004
Pharmacodynamics in the development of new immunosuppressive drugsChristoph Burkhart, Christoph Heusser, Randall E Morris, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chainThomas Ullrich, Karl Baumann, Karl Welzenbach, et al.
Immunology|December 5, 2006
Statins inhibit lymphocyte homing to peripheral lymph nodesRené Schramm, Michael D Menger, Yves Harder, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,4-Diazepane-2-ones as novel inhibitors of LFA-1Sompong Wattanasin, Rainer Albert, Claus Ehrhardt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 7, 2007
Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasiaBehzad Soleimani, Grazyna Wieczorek, Andreas Katopodis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Developmental control of integrin expression regulates Th2 effector homingSeung-Hyo Lee, Joseph E Prince, Muhammad Rais, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1Sompong Wattanasin, Joerg Kallen, Stewart Myers, et al.
Biochemical Pharmacology|March 15, 2023
Allosteric targeting resolves limitations of earlier LFA-1 directed modalitiesRiccardo V Mancuso, Gisbert Schneider, Marianne Hürzeler, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2009
The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activationJean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Therapeutic Drug Monitoring|December 1, 2004
Pharmacodynamics in the development of new immunosuppressive drugsChristoph Burkhart, Christoph Heusser, Randall E Morris, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chainThomas Ullrich, Karl Baumann, Karl Welzenbach, et al.
Immunology|December 5, 2006
Statins inhibit lymphocyte homing to peripheral lymph nodesRené Schramm, Michael D Menger, Yves Harder, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,4-Diazepane-2-ones as novel inhibitors of LFA-1Sompong Wattanasin, Rainer Albert, Claus Ehrhardt, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 7, 2007
Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasiaBehzad Soleimani, Grazyna Wieczorek, Andreas Katopodis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2008
Developmental control of integrin expression regulates Th2 effector homingSeung-Hyo Lee, Joseph E Prince, Muhammad Rais, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1Sompong Wattanasin, Joerg Kallen, Stewart Myers, et al.
Biochemical Pharmacology|March 15, 2023
Allosteric targeting resolves limitations of earlier LFA-1 directed modalitiesRiccardo V Mancuso, Gisbert Schneider, Marianne Hürzeler, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2009
The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activationJean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke, et al.
Pageof 3